Table 4.
Medication regimens and treatments used in patients with COVID-19
| Medication regimens and treatments | Total (%) No (%) |
Lethal Outcome No (%) |
Survived No (%) |
p-value | |
| OST + HCQ + LPV/r | Yes | 1007 (45.7) | 38 (37.2) | 969 (46.1) | 0.056 |
| No | 1202 (54.3) | 65 (62.8) | 1137 (53.9) | ||
| Intubation | Yes | 303 (13.7) | 89 (87.3) | 214 (10.2) | 0.001 |
| No | 1901 (86.3) | 13 (12.7) | 1888 (89.8) | ||
| Mechanical intubation | Yes | 264 (12.0) | 73 (71.6) | 191 (9.1) | 0.001 |
| No | 1940 (88.0) | 29 (28.4) | 1911 (90.9) | ||
| Recigen + Vit D + Remdesivir | Yes | 259 (11.8) | 7 (6.9) | 252 (12.0) | 0.116 |
| No | 1945 (88.2) | 95 (93.1) | 1850 (88.0) | ||
| Recigen + Vit D | Yes | 109 (4.9) | 1 (1.0) | 108 (5.1) | 0.059 |
| No | 2095 (95.1) | 101 (99.0) | 1994 (94.9) | ||
| OST + HCQ | Yes | 93 (4.2) | 6 (5.9) | 87 (4.1) | 0.442 |
| No | 2111 (95.8) | 96 (94.1) | 2015 (95.9) | ||
| Plasma therapy | Yes | 58 (2.6) | 6 (5.9) | 52 (2.5) | 0.049 |
| No | 2146 (97.4) | 96 (94.1) | 2050 (97.5) | ||
| Recigen or Zifron | Yes | 27 (1.2) | 0 (0.0) | 27 (1.0) | 0.634 |
| No | 2177 (98.8) | 102 (100.0) | 2075 (98.7) | ||
| OST + HCQ + LPV/r + Ribavirin | Yes | 6 (0.3) | 1 (1.0) | 5 (0.2) | 0.248 |
| No | 2198 (99.7) | 101 (99.0) | 2097 (99.8) | ||
| OST + HCQ | 93 (4.3) | 6 (6.9) | 87 (4.1) | ||
| OST + HCQ + LPV/r | 1007 (45.7) | 38 (37.2) | 969 (46.1) | ||
| None | 1102 (50.0) | 57 (55.9) | 1045 (49.8) | ||
| Recigen + Zifron + Vit D | 103 (4.7) | 1 (1.0) | 102 (4.8) | ||
| Recigen + Zifron + Vit D + Remdesivir | 275 (12.5) | 7 (6.9) | 268 (12.7) | ||
| None | 1800 (82.8) | 94 (92.1) | 1706 (82.5) |
Abbreviations: OST: oseltamivir, HCQ: hydroxychloroquine, LPV/r: lopinavir / ritonavir, Vit: vitamin